Daniel Price

Daniel Price has extensive work experience in the field of computational chemistry and drug discovery. Daniel is currently serving as the Executive Director at Nimbus Therapeutics since January 2022. Prior to this, they worked at GSK for over 15 years, starting in March 2006 and holding the position of Director in Computational Chemistry until January 2022. Before joining GSK, they served as a Postdoctoral Research Fellow at The Scripps Research Institute from November 2000 to February 2006.

Daniel Price obtained their Bachelor of Science (B.S.) degree in Chemical Engineering from the University of Colorado, Boulder, which they attended from 1991 to 1995. Daniel then pursued a Ph.D. in Molecular Biophysics and Biochemistry at Yale University from 1995 to 2000.